Corsano Health’s Post

Thoughts on this? >> Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab >> Comment below! >>> lqventures.com #mhealth #AI #healthtech #industry40 #IoT

We can mimic heart activity for weeks now in a digital twin Understanding the evolving physiological state of a patient, particularly during daily activities, is key to early detection and disease monitoring. Recently, and as predicted many years ago, the creation of human digital twins thereto has become a central goal in biomedicine. A recent study by Amanda Randles and team Duke University published in Nature npj Digital Medicine presents a breakthrough framework for wearable-driven coronary digital twins, allowing continuous, personalized monitoring of heart health over extended periods. Considering that cardiovascular diseases evolve over months to years, improving our ability to track blood flow over longer periods with 3D digital twins could reveal new biomarkers, potentially revolutionizing standard of care practices. The authors' approach offers unprecedented insights into cardiovascular dynamics for 6 weeks (versus a few seconds till now) and could revolutionize proactive healthcare. Here is the read: https://lnkd.in/ejct75TV More on this topic to come. #digitalhealth #mhealth #wearables #prediction #digitaltwin Digital Twin Consortium #cardiology #heart

By integrating #AI with commonly used medical devices like stethoscopes, we’re not only enhancing their functionality but also making advanced diagnostics #accessible in both urban and remote locations. This democratization of healthcare technology promises to bridge gaps in care delivery, especially in underserved areas, and paves the way for a future where #preventive medicine is within everyone’s reach. Eko Health achieves a groundbreaking #FDA clearance for its AI program, integrated with digitally enhanced stethoscopes to detect low ejection fraction, a crucial indicator of #heartfailure , through a non-invasive method. Collaboration with Mayo Clinic ensuring clinical relevance and reliability. Over 3 million people in the U.S. could benefit from this technology. Trained on over 100,000 pairs of electrocardiograms and ultrasound exams, showing 74.7% sensitivity and 77.5% specificity. Imperial College London study confirms effectiveness with 84.8% sensitivity in #realworldevidence settings. #digitalhealth #healthcareai #cardiology #wearables #diagnosticai

Fascinating advancements in wearable-enabled biomarker research! The future of health monitoring is here, and I am honored to work alongside the hardworking team at rce.ai. Imagine the impact this could have on early disease detection and prevention.. lets keep striving!!! #HealthTech #Innovation #cardiovascular #WearableTech #Healthcare #BiomarkerResearch #Innovation #HealthInnovation #TechProgress #HealthcareRevolution #ArtificialIntelligence

𝐑𝐚𝐝𝐢𝐚𝐭𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 & 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐫𝐨𝐬𝐩𝐞𝐜𝐭𝐬 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gCXphsd2 The Radiation Therapy & Diagnostic Imaging Equipment Market comprises equipment used to diagnose, monitor, and treat conditions such as cancer, cardiovascular diseases, neurological disorders, and other chronic ailments. This market includes a range of imaging modalities like X-ray, MRI, CT, PET, and SPECT systems, as well as radiation therapy devices, including linear accelerators, brachytherapy systems, and proton therapy systems. Increasing prevalence of chronic diseases, technological advancements in imaging, and rising investments in healthcare infrastructure are major drivers fueling the market’s expansion. 𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 Rising Cancer Incidence: With a globally increasing number of cancer cases, there is heightened demand for radiation therapy and diagnostic imaging to enable timely and precise diagnosis and treatment. Technological Advancements: Innovations such as AI-integrated imaging, high-definition MRI, and next-generation CT imaging are improving diagnostic accuracy, reducing scan times, and enhancing patient comfort, leading to widespread adoption. Increased Healthcare Expenditure: Governments and private sectors are investing in healthcare infrastructure and advanced diagnostic equipment, especially in emerging economies, thereby boosting market growth. Growing Aging Population: The aging population is more susceptible to chronic diseases, increasing demand for diagnostic imaging and radiation therapy to monitor and treat these conditions. #Company GE HealthCare Siemens Healthcare Pvt. Ltd. Philips Toshiba Neurológica Neusoft Medical Shenzhen Anke High-Tech Co.,Ltd. United Imaging Healthcare #Type Computed Tomography (CT) Scanners Magnetic Resonance Imaging (MRI) Systems Linear Accelerators CT Simulators Others #Applications Hospitals Clinics Others 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐁𝐮𝐲 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gEWneqzU #RadiationTherapy #DiagnosticImaging #CancerTreatment #MedicalImaging #HealthcareTechnology #Oncology #Radiology

Exciting News in the World of Medicine! Scientists have just created an AI-powered system that can track ingestible devices used to monitor disease markers in the gut. This groundbreaking technology offers a non-invasive approach to monitor gastrointestinal (GI) tract health from the comfort of your own home. The system combines wearable coil technology with artificial intelligence to precisely locate the ingestible device and measure gas concentrations in real-time. This enables accurate tracking of the device's location within the GI tract and provides valuable insights into overall gut health. The potential applications of this system are immense. Individuals at risk of gastrointestinal diseases or disorders can now monitor their health without undergoing invasive tests in hospital settings. Imagine the convenience of tracking your gut health while going about your daily life! Further research and development are still underway. Scientists aim to refine the device and conduct human trials in the future to ensure its efficacy and reliability. This will pave the way for better diagnostics and personalized treatment options for GI-related conditions. Stay tuned for more updates on this fascinating innovation in gut health monitoring! The future of healthcare is becoming increasingly personalized, empowering individuals to take charge of their well-being like never before. Read more: https://lnkd.in/gM7_8Pnt #DHPSP2024 #AIinMedicine #GutHealthMonitoring #HealthcareInnovation #PersonalizedHealthcare

Registration (free of charge) form: https://lnkd.in/dPMUR3Fj CNR-IEIIT "Thursday seminars" Tuesday 16 May 2024 at 17:30 (CET, UTC +1) the on-line seminar will take place which will have Dr.-Ing. Can Dincer (IMTEK & FIT, University of Freiburg) as speaker with the following contribution: Speaker: Dr.-Ing. Can Dincer (IMTEK & FIT, University of Freiburg) Title: Disposable sensors for next-generation diagnostics Abstract: Disposable sensors are low-cost and easy-to-handle sensing devices for short-term or single-shot measurements. Over the last decade, they have become increasingly important for medical applications, especially for the point-of-care and wearable diagnostics. In this talk, first a brief introduction to disposable sensors will be given. Afterwards, different biosensing approaches, developed in my research group, for next-generation diagnostics will be presented: (i) Multiplexed on-site therapeutic drug monitoring of antibiotics from invasive and non-invasive samples toward personalized antibiotherapy, (ii) CRISPR-powered electrochemical biosensors for target amplification-free, simultaneous and on-site detection of multiple nucleic acids and other (bio)molecules (such as proteins or drugs) for the management of infectious diseases, (iii) wearable microfluidic immunosensing devices for lab-on-a-bird applications and beyond, (iv) low-cost electrochemical paper-based wearable sensors that can be integrated to any type of facemask for wearable and continuous monitoring of breath biochemistry and/or testing of the infectious diseases such as coronaviruses from exhaled breath, and (v) light-controlled dynamic bioassays using optogenetic switches (OptoAssays) for wash- and pump-free point-of-care diagnostics. #Disposable #Sensors #nextgeneration #diagnostics #IEIIT #CNR

Thoughts on this? >> AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #AI #mhealth #IoT #healthtech #industry40

🧠 Bringing #MultipleSclerosis care from hospitals to homes! What if patients could track their condition and receive tailored rehabilitation— all from the comfort of their homes? Together with Myelin-H, LIST is turning this vision into reality through a project, which leverages cutting-edge Software-as-a-Medical Device technology, integrating: ➡️ Neuroscience-based mobile games. ➡️Wearable sensors tracking brain activity, muscle function, and speech. ➡️AI-powered clinical scores to provide real-time insights for doctors. This approach empowers early intervention, personalized treatments, and neurorehabilitation. 🌐 From Italy to the USA, the platform is being clinically validated while ensuring data privacy with state-of-the-art GDPR-compliant tech. This innovation could transform care for other #neurodegenerative diseases like #Parkinson’s, reshaping #healthcare worldwide. Lucien Hoffmann Dr Zied Tayeb Djamel KHADRAOUI Alessandro Pincherle Orhan Ermiş

From Luxembourg to the UK and the USA, Myelin-H’s brain-machine interface platform is being clinically validated for its ability to remotely monitor and provide game-based, personalised neurorehabilitation programmes for patients with neurological disorders, starting with #MultipleSclerosis. By combining neuroscience-based mobile games with AI, we’re shaping the future of healthcare: smarter, more personalised, and closer to home. Shoutout to the brilliant team and collaborators: Lucien Hoffmann, Djamel KHADRAOUI, Alessandro Pincherle, and Orhan Ermiş. 👏 #Neurotech #HealthcareInnovation #AI #Rehabilitation